- Home
- RNAZ vs CREG Comparison
RNAZ vs CREG Comparison
Compare RNAZ & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- CREG
- Stock Information
- Founded
- RNAZ 2016
- CREG 1980
- Country
- RNAZ United States
- CREG China
- Employees
- RNAZ N/A
- CREG N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- CREG Power Generation
- Sector
- RNAZ Health Care
- CREG Utilities
- Exchange
- RNAZ Nasdaq
- CREG Nasdaq
- Market Cap
- RNAZ 7.2M
- CREG 6.1M
- IPO Year
- RNAZ 2021
- CREG N/A
- Fundamental
- Price
- RNAZ $0.53
- CREG $0.63
- Analyst Decision
- RNAZ Strong Buy
- CREG
- Analyst Count
- RNAZ 1
- CREG 0
- Target Price
- RNAZ $20.00
- CREG N/A
- AVG Volume (30 Days)
- RNAZ 16.6M
- CREG 78.1K
- Earning Date
- RNAZ 05-14-2025
- CREG 05-13-2025
- Dividend Yield
- RNAZ N/A
- CREG N/A
- EPS Growth
- RNAZ N/A
- CREG N/A
- EPS
- RNAZ N/A
- CREG N/A
- Revenue
- RNAZ N/A
- CREG N/A
- Revenue This Year
- RNAZ $180.81
- CREG N/A
- Revenue Next Year
- RNAZ N/A
- CREG N/A
- P/E Ratio
- RNAZ N/A
- CREG N/A
- Revenue Growth
- RNAZ N/A
- CREG N/A
- 52 Week Low
- RNAZ $0.43
- CREG $0.53
- 52 Week High
- RNAZ $66.33
- CREG $1.57
- Technical
- Relative Strength Index (RSI)
- RNAZ 28.52
- CREG 39.38
- Support Level
- RNAZ $0.43
- CREG $0.67
- Resistance Level
- RNAZ $0.61
- CREG $0.81
- Average True Range (ATR)
- RNAZ 0.17
- CREG 0.07
- MACD
- RNAZ 0.21
- CREG -0.01
- Stochastic Oscillator
- RNAZ 8.24
- CREG 27.16
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company currently offer waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.